In our recently published study on IRI-induced AKI rats, we also observed a significant increase in the level of CD38 after 24 h and 14 days post-IRI, which we suggested to be a factor that reduces the level of NAD+ in post-IRI subjects [118]. The gene discussed is CD38; the disease is acute kidney injury.